Evidence map›Paper›PMID 12487379›Full record

ArticleMolecular and cellular biochemistry2002

Regulation of catalase enzyme activity by cell signaling molecules.

Sumio Yano, Noriko Yano

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Targeting catalase in cancer.Redox biology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. 17β-Estradiol Concentration and Direct βAnnals of neurosciences · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Evolution of catalases from bacteria to humans.Antioxidants & redox signaling · 2008
    Review
  17. Catalase enzyme mutations and their association with diseases.Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology · 2004
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sumio YanoDepartment of Biochemistry, Ponce School of Medicine, Ponce, Puerto Rico, USA. yanos@coqui.net
Noriko Yano
Ponce Health Sciences University · PR

Funding

Therapeutic Immunization in Monkey Model of AIDSS06GM008239 · NIGMS · PONCE SCHOOL OF MEDICINE · PI MATTA, JAIME L · 1989 to 2009
$21.5M
Nutritional Regulation of Catalase and Colorectal CancerR03ES011474 · NIEHS · PONCE SCHOOL OF MEDICINE · PI YANO, SUMIO · 2001 to 2002
$156k
NIEHS NIH HHS R03 ES11474-01NIGMS NIH HHS S06GM08239
6 · The paper itself

Abstract

Mitogenic cell proliferation requires a rapid and transient H2O2 generation, which is blocked by catalase or PKA activators. Previously, we observed that anemic HIV(+) individuals expressed acidic pIs of catalase in RBC with significantly high activities [Mol Cell Biochem 165: 77-81, 1996]. These findings led us to hypothesize that cell signaling molecules regulate catalase to control cell mitogenesis. To test the hypothesis, we determined (i) whether RBC counts correlate with their catalase activities, (ii) whether protein kinases and phosphatases alter catalase activity in vitro, and (iii) whether protein kinase activators increase catalase activity to suppress proliferation of cultured cells. The results indicated that RBC counts inversely correlated with RBC catalase activities in both HIV(+) (r: -0.6769, r2: 0.4582, n: 69 male, p < 0.0001) and HIV(-) (r: -0.3827, r2: 0.1464, n: 177 male, p < 0.0001) populations. Catalytic PKA, PKC and Casein Kinase II, but none of PKG, Ca2+/calmodulin kinase II and p34cdc/cyclinB, rapidly elevated catalase activity in vitro by up to 2-fold. Whereas a major CAT subunit (60 kDa) showed immunoreactive phosphoserine and phosphothreonine, the kinases- and gamma-32P-ATP-dependent phosphorylation occurred with a minor component (110 kDa). Among PKC isozymes examined, PKCzeta was the most effective modulator followed by PKCgamma, and protein phosphatase 1gamma and 2A decreased the catalase activity. PKA and PKCzeta activators of forskolin and okadaic acid increased catalase activity and 110 kDa expression in NIH3T3 cells up to 2.4-fold and suppressed the cell growth, showing an inverse correlation of the indices (r: -0.9286, r2: 0.8622, n: 18, p < 0.0001). Taken together, these results suggest for the first time that catalase is under the regulation of cell signaling molecules and capable of modulating mitogenic cell proliferation.

Indexed as

MitosisSignal Transduction3T3 CellsAdultAnimalsBlotting, WesternCatalaseElectrophoresis, Polyacrylamide GelErythrocyte CountErythrocytesFemaleHIVHumansHydrogen PeroxideMaleMiceCatalaseHydrogen PeroxideProtein Kinases

Identifiers

PMID12487379
OpenAlexW1589654767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.